Pearl River Capital, LLC Vertex Pharmaceuticals Inc Transaction History

Pearl River Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $366,105 - $400,579	898 New	898 $375,000
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $2.32 Million - $2.61 Million	8,104 New	8,104 $2.34 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $1.71 Million - $2.16 Million	-9,672 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $1.75 Million - $1.96 Million	9,672 New	9,672 $1.75 Million
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $1.71 Million - $2.02 Million	-6,671 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$225.48 - $295.8 $1.23 Million - $1.62 Million	5,469 Added 454.99%	6,671 $1.94 Million
Q4 2019 Feb 12, 2020	BUY	$166.71 - $223.91 $200,385 - $269,139	1,202 New	1,202 $263,000
Q2 2019 Aug 12, 2019	SELL	$164.61 - $190.37 $38,518 - $44,546	-234 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$163.73 - $194.7 $38,312 - $45,559	234 New	234 $44,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.